Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05943262
Collaborator
(none)
100
1
1
44
2.3

Study Details

Study Description

Brief Summary

The research aims to develop a novel pathological technology, including rapid whole-mount tissue H&E & IHC staining protocol and high-resolution nonlinear optical microscopy imaging system, to intraoperatively assess brain tumor grade, types and other biological parameters.

Condition or Disease Intervention/Treatment Phase
  • Device: mesoscale nonlinear optical microscope
N/A

Detailed Description

Brain tumors, especially like glioma, the infiltrative growth pattern resulted in an indistinct margin against normal brain tissues. Surgery is currently the most effective method in prolonging patient's survival, the extent of tumor resection is therefore crucial to the overall outcome. Distinguishing the tumor type and grading can help neurosurgeons plan the intraoperative surgical strategies to cure the suffered patients. Feasible solutions to improve the extent of resections including fluorescence-guided surgery and intraoperative MR imaging are relatively indirect to judge the completeness of tumor resection and its margin; considering means like Moh's surgery performed in the dermatological practice, though it is reasonable to look at the resection proportion by pathological interpretation, it is very time consuming. Besides, many kinds of brain tumors can't be classified only by the outcomes of frozen pathology. There are several related studies trying to solve the problem, but the judgment criteria is not sufficient to meet the standard of modern pathological diagnosis. The research aims to acquire images by optical microscopy from both H&E and IHC stained tissues, and to compare those images with slides obtained by standard pathological workflow in order to achieve accurate and rapid assessment of tumor categories and grading.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling
Actual Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2026
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: mesoscale nonlinear optical microscope + whole-mount H&E & IHC staining protocol

Device: mesoscale nonlinear optical microscope
The mesoscale nonlinear optical microscope based on the principles of nonlinear optics and computed-algorithms can acquire large-area image within few minutes.

Outcome Measures

Primary Outcome Measures

  1. Develop a standard whole-mount tissue processing protocol [3 years]

    In this research, the investigators will try to create a standard staining protocol to perform rapid whole-mount H&E and IHC staining on surgical brain tumor specimens, so that the cell morphology (ex: cell shape, cell size, etc) and cell types (ex: astrocytes, oligodendrocytes, T-cells, B-cells, etc) in the images of those tissues can be observed via nonlinear optical microscopy, and the treatment strategy can be set based on subtyping and grading the brain tumors by the pathologists.

  2. Obtain images from H&E and IHC stained brain tumor tissues by nonlinear optical microscopy [3 years]

    Images of brain tumor specimens will be taken by nonlinear optical microscopy and a image database of brain tumors can be created (ex: cell shape, cell size and cell density of different cells in human brain tissues).

Secondary Outcome Measures

  1. Distinguish between normal tissue and brain tumor and determine the extent and grade of the brain tumors [3 years]

    By interpreting the images acquired from nonlinear optical microscope of the two staining methods and the images obtained by bright field microscope for pathologists with standard procedures, an attempt is made to distinguish between normal tissue and brain tumor and determine the extent and grade of those brain tumors (depending on tumor characteristics, such as hypercellularity, microvascular proliferation, necrosis, etc).

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients older than the age of 20 with diagnosis of brain tumor (both newly-diagnosed or recurrent) who are suitable and willing to receive resection surgery.
Exclusion Criteria:
  1. Patients who cannot give consent to participate in the study.

  2. The tumor samples failed to give a conclusive pathological diagnosis by standard pathological workflow.

  3. Patients who only receives biopsy surgery rather than resection surgery.

  4. Significant post-irradiation effect or radiation necrosis reported in the pathological examination.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University Taipei Taiwan

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT05943262
Other Study ID Numbers:
  • 202302070RIND
First Posted:
Jul 13, 2023
Last Update Posted:
Jul 13, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2023